A study to find the ideal concentration of Propofol which is used for sedation by a special pump for taking biopsy from the uterus
Phase 2
- Conditions
- Health Condition 1: N80-N98- Noninflammatory disorders of female genital tract
- Registration Number
- CTRI/2019/05/019151
- Lead Sponsor
- Madhula P
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA1 and 2 patients 40 to 70 years age group
Exclusion Criteria
Patient refusal for sedation. Patients with risk of aspiration. Patients with reactive airway disease. Difficult airway. Obesity BMI more than 35. Patients with allergic to study drugs
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study adequacy of anaesthesia by patient movement with varied effector site concentration of Propofol. To study hemodynamic and respiratory changes with varied effector site concentration of Propofol. To identify surgical step that produces maximum stimulus by recording surgical step at which patient moves(holding of cervix, cervical dilatation, curettage of endometrium)Timepoint: 3 years
- Secondary Outcome Measures
Name Time Method To measure plasma concentration of Propofol and to compare with calculated plasma concentration in TCI pumpTimepoint: 3 years